Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for Cisplatin Nephroprotection in Pediatric Oncology
NCT06196853Phase 3Not yet recruiting
- Sponsor
- Mahidol University
- Start
- Dec 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aminophylline in acute kidney injury (AKI), renal tubulopathy, sponsored by Mahidol University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
aminophylline
03
Conditions
acute kidney injury (AKI)renal tubulopathy
Beyond the preview
Go deeper on NCT06196853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06196853.